leadf
logo-loader
viewZelira Therapeutics Ltd

Zelira Therapeutics forms subsidiary to launch hemp-derived oral care products in the USA

Zelira has formed a new oral-healthcare subsidiary to commercialise a new line of hemp-derived cannabinoid-based oral care products.

Zelira Therapeutics Ltd - Zelira Therapeutics forms subsidiary to launch oral care products in the USA
Commercialisation activities are expected to begin in quarter four 2020

Zelira Therapeutics Ltd (ASX:ZLD) (OTCMKTS:ZLDAF) has formed an oral care products subsidiary to commercialise scientifically formulated, hemp-derived cannabinoid-based oral care products in the USA.

The first oral care product will be a cannabinoid-containing proprietary toothpaste formulation developed by Sprinjene CEO and founder Dr Sayed Ibrahim.

Zelira is on-track to launch its first over-the-counter product, a proprietary cannabinoid containing toothpaste formulation in the USA by quarter four 2020.

“First over-the-counter product”

Zelira CEO and managing director USA markets Dr Oludare Odumosu said: “Zelira is pleased to partner with Dr Ibrahim to commercialise these new and advanced oral care cannabinoid-based products.

“Our products will be available for sale in the USA by quarter four 2020 and we remain focused on unlocking the benefits of cannabinoid-based applications as we expand our company’s reach into new and lucrative markets.

“This will be the first over-the-counter (OTC) product line launched by Zelira.”

Oral care market

Dr Ibrahim said: “The Sprinjene team is excited about the partnership with Zelira Therapeutics and we look forward to the impact that our products will have in the oral care market.

“Our collaboration to commercialise the most advanced hemp-derived cannabinoid-based oral care products expands our reach into new oral care markets where every person can access the daily benefit of using our products.”

Commercialisation in quarter four

The company has entered into an agreement with USA-based SprinJene and Health and Natural Beauty USA Corp to manufacture its oral care products.

Sprinjene Gluten-Free, Cruelty-Free, Vegan, Kosher, USDA Bio-preferred and Halal oral care products are currently manufactured by Health and Natural Beauty USA Corp.

The company remains on track to launch five new products in global markets in 2020.

Quick facts: Zelira Therapeutics Ltd

Price: 0.066 AUD

ASX:ZLD
Market: ASX
Market Cap: $75.39 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Zelira Therapeutics Ltd named herein, including the promotion by the Company of Zelira Therapeutics Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Zelira Therapeutics with Proactive at ASX Small and Mid-Cap Conference

Zelira Therapeutics Ltd (ASX:ZLD) managing director Richard Hopkins speaks to Proactive’s Andrew Scott at the virtual ASX Small and Mid-Cap Conference 2020.  The medicinal cannabis company owns a portfolio of proprietary revenue-generating products and a pipeline of candidates undergoing...

1 week, 2 days ago

2 min read